CVE-2020-10627
What it is
Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.
At a glance
- Exploitability
- Can be exploited locally on the machine without logging in. High risk of data tampering.
- Exploit odds
- 0.5% chance of exploitation in the next 30 days (EPSS).
- Fix
- A patch, advisory or fixed version is referenced. Upgrade or apply it.
Timeline
- PublishedDisclosed publicly on CVE.org and NVD
- Last updatedMost recent change to the record
Why it ranks here
- Exploited in the wild: no, CISA does not list it.
- Exploit odds: 0.5% in the next 30 days (EPSS).
- Severity: 7.3 HIGH (CVSS).
- Fix: a patch or advisory is linked.
Details
- Published
- Last modified
- Exploit probability
- 0.5% · EPSS, next 30 days
- Weakness
- CWE-284 · Improper access control
- Record status
- Modified
Affected
- Insulet Omnipod Insulin Management System Firmware
Attack profile CVSS 3.1 · 7.3
- Attack vector
- Local
- Complexity
- Low
- Privileges needed
- None
- User interaction
- None
- Scope
- Unchanged
- Confidentiality
- Low
- Integrity
- High
- Availability
- Low
Raw vector
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:L
Is it in your code?
Hand this to your coding agent. It searches your project for the affected products and checks versions. Nothing leaves your machine.
Read https://cve-list.com/agent/cve/CVE-2020-10627.md and follow it. Check whether this project is affected by CVE-2020-10627. Read only. Don't change anything and don't upload my code. Tell me yes, no or not sure, with the file as proof.
